Updated: May 19, 2026

Edward C English

XLOXilio Therapeutics, Inc.SEC CIK: 0001302600
Estimated Net Worth
$5.76 Million
Last Updated: May 19, 2026 03:24 AM EST

Transaction Summary

Total Transactions25
Buy-Sell Ratio0.00
Buy Transactions0
Sell Transactions9

Transaction Volume

Total Volume-$5.75M
Net Volume$5.75M
Buy Volume$0
Sell Volume-$5.75M

Trade Analysis

AVG Trade Size-$231.86K
Largest Trade$0
Most Active MonthMar
Most Active Year2016

Trading Sentiment

OverallBullish
Recent TradeNeutral
Last 90 Days0 Trades
ConvictionNone

Net Worth & Trading Activity Over Time

Loading...

Monthly Trading Pattern

Loading...

Past Insider Trading and Trends

Edward C English has an estimated net worth of $5.76 Million. This is based on reported shares across multiple companies, which include TESARO, Inc., Xilio Therapeutics, Inc., AMAG PHARMACEUTICALS INC., and PRAECIS PHARMACEUTICALS INC.



2016 was Edward C English's most active year for acquiring shares with 10 total transactions. Edward C English's most active month to acquire stocks was the month of February. 2016 was Edward C English's most active year for disposing of shares, totalling 17 transactions. Edward C English's most active month to dispose stocks was the month of May. 2017 saw Edward C English paying a total of $945,883.16 for 33,887 shares, this is the most they've acquired in one year. In 2017 Edward C English cashed out on 59,578 shares for a total of $4,465,250.71, their largest year based on trade value.

Holdings & Transactions

XLOxilio therapeutics, inc.
PRINCIPAL ACCOUNTING OFFICER
Updated: Jan 04, 2023VIEW QUOTE
Form TypeSEC Filing
24.00K24.00KJan 01View
6.00KView
tesaro, inc.
VP Finance & Administration Officer
Updated: Sep 06, 2017
Form TypeSEC Filing
-0.3110.86K$86.67-$1.05M24.53KScheduledSep 06View
-0.348.50K$83.39-$939.53K16.40KScheduledJun 06View
-0.2910.00K$103.51-$1.49M24.90KScheduledMar 06View
1.473.67K$177.61-$40.67K6.17KScheduledMar 01 - 02View
-0.2910.00K$79.22-$996.67K25.00KScheduledDec 12View
-0.257.00K$56.04-$455.13K20.57KScheduledSep 08View
-0.207.00K$32.14-$120.60K27.57KScheduledJun 10View
-0.177.00K$33.62-$141.27K34.57KScheduledMar 10View
15.50K15.50KMar 01View
-0.3917.00K$34.88-$520.58K26.57KScheduledDec 10View
25.00K25.00KMar 06View
10.00K10.00KMay 08View
25.00K25.00KFeb 27View
0.3625.00K93.57KFeb 27View
0.2815.00K68.57KAug 30View
25.00K25.00KMar 06View
View
amag pharmaceuticals inc.
VP, Controller, Interim CFO Officer
Updated: Jun 28, 2011
Form TypeSEC Filing
88.00View
praecis pharmaceuticals inc
VP, CFO, Treasurer & Ass. Sec. Officer
Updated: Feb 08, 2007
Form TypeSEC Filing
-1.0021.95K$3.33-$42.78KFeb 07View
100.00K109.78KMay 27View
54.00K63.78KNov 11View
25.00K34.78KSep 16View
9.78KView